A knowledge-guided analysis approach to recovering rare signals from single-cell transcriptomic data

Active Project Grant Awarded Last action

Award ID
R21GM159319
Recipient
Awarding agency
Obligated
$536,250

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date 66% complete
Place of performance
La Jolla, CA 92037, USA

Award details come from USAspending.gov.

About this award

This $536,250 Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports computational method development to advance single-cell transcriptomic data analysis. Awarded to Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, the project runs from July 1, 2025 through June 30, 2027 and develops knowledge-guided algorithms designed to improve the detection and clustering of rare cell populations in single-cell transcriptomic datasets. The research addresses a critical limitation in current analysis pipelines where dimensionality reduction steps inadvertently discard rare signals, making identification of biologically important rare cells—such as tissue stem cells, senescent cells, and tumor-initiating cells—difficult or impossible.

The project delivers novel computational methods utilizing autoencoder artificial neural networks enhanced with external knowledge inputs to preserve marker gene information during dimensionality reduction. This approach enables researchers to supply gene information as knowledge guidance, allowing rare cells and highly similar cell sub-populations to remain clustered and identifiable in processed datasets. The resulting tools and methodologies will support improved analysis of single-cell transcriptomic data across biomedical research applications, advancing the foundation for disease understanding and therapeutic development.

Description

Abstract
This innovative project aims at developing computational methods that overcome a major limitation of existing single-cell transcriptomic data analysis methods. Single-cell transcriptomics has enabled profiling of gene expression in individual cells. This is particularly useful for studying rare cells because their data are largely invisible if mixed together with other cells in a bulk sample. There are many examples of biologically important rare cells, such as tissue stem cells, senescent cells, endothelial progenitors, and tumor-initiating cells. Ironically, existing analysis methods for single-cell transcriptomic data often ignore rare cells. This is because in a standard step included in all mainstream analysis pipelines called dimensionality reduction, rare signals can easily be discarded in order to preserve the most prominent signals. As a result, rare cells are usually not clustered together in the reduced data, which in turn makes IT difficult to identify and study these cells. To tackle this problem, here we propose the novel concept of knowledge-guided single-cell data analysis. Taking marker genes of cells of interest as externally-supplied knowledge, our algorithm will be instructed to retain information about these genes during dimensionality reduction. As a result, the rare cells are much more likely to be clustered in the reduced data. Another important application of our methods is separating highly similar cell sub-populations. By supplying genes differentially expressed (degs) between them as knowledge input, they will become more separated in the reduced data. In aim 1, we will design and implement the computational methods. We will use the autoencoder artificial neural network framework, which is proven to be useful for single-cell data, and introduce novel components to take and use the external knowledge. A key aspect of our methods will be that both the external knowledge and the data itself will be respected, which means the dimensionality reduction process will pay attention to the marker genes/degs only if the most prominent signals in the data can also be preserved at the same time. In aim 2, we will systematically test the effectiveness of our methods in identifying rare cells and separating highly similar cell sub-populations using published data sets. We will use independent data to define cell populations, such as cell surface protein measurements in cite-SEQ, and use them to quantitatively assess how well our methods cluster rare cells and separate different cell sub- populations. We will benchmark against state-of-the-art single-cell data analysis methods. In aim 3, we will assess the effects of having noisy and incomplete knowledge inputs. The former refers to genes not specifically expressed in a rare cell type or not differentially expressed between cell sub-populations, while the latter refers to specifically/differentially expressed genes that are not supplied as knowledge input. We will artificially include noisy genes and exclude informative genes to study tradeoffs between comprehensive yet noisy and precise yet incomplete knowledge inputs. Overall, this project will produce computational methods and open-source software that will propel the study of important rare signals in single-cell transcriptomic data.

Quick answers

Who received award R21GM159319?

R21GM159319 was awarded to Sanford Burnham Prebys Medical Discovery Institute by National Institute of General Medical Sciences (National Institutes of Health) on July 1, 2025.

How much is award R21GM159319 worth?

$536,250 has been obligated on R21GM159319.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award